Acute rejection after liver transplantation: Is there a specific immunological pattern?

Area of Science:

• Immunology
• Transplantation Science

Background:

• Acute rejection is a major complication following liver transplantation.
• Understanding the specific immune mechanisms involved in early acute rejection is crucial for improving patient outcomes.

Purpose of the Study:

• To investigate T-cell subset profiles and cytokine secretion in liver tissue and peripheral blood of liver transplant recipients.
• To identify immunological markers associated with early acute rejection episodes after liver transplantation.

Main Methods:

• Flow cytometry was used to analyze CD4+ CD7+, CD8+ CD38+, and CD4+ CD25+ T cells.
• ELISpot assay measured interleukin (IL)-2 and IL-10 secretion to assess Th1-like responses and regulatory T (Treg) cell activity.
• Comparison between patients with and without acute rejection.

Main Results:

• Histologically confirmed early acute rejection occurred in 42% of patients within 4 weeks post-transplant.
• Patients with acute rejection exhibited higher CD4+ CD7+ and CD8+ CD38+ T cell expression in the liver compared to peripheral blood.
• A significant reduction in liver Treg cells was observed in patients experiencing acute rejection.

Conclusions:

• Early acute liver transplant rejection is associated with a local increase in specific effector T-cell subsets.
• A decrease in regulatory T (Treg) cells within the liver microenvironment suggests impaired immune tolerance.
• These findings indicate a localized Th1-like immune response and reduced Treg cell function in acute liver rejection.